David C. Griffith
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 39
- Pharmacology 38
- Antibiotics Pharmacokinetics and Efficacy 38
- Co-authors
- Michael N. Dudley (32 shared papers)Mojgan Sabet (13 shared papers)Olga Lomovskaya (6 shared papers)Ziad Tarazi (12 shared papers)Debora Rubio-Aparicio (5 shared papers)Mark A. Miller (1 shared paper)Louise A. Kelly‐Hope (1 shared paper)Dongxu Sun (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (28 papers)Open Forum Infectious Diseases (6 papers)The Journal of Antibiotics (2 papers)Journal of Adolescent Health (2 papers)Journal of Cystic Fibrosis (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
David C. Griffith
66 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 118
- Molecular Medicine 1.6k
- Applied Microbiology and Biotechnology 401
- Pharmacology 1.1k
- Endocrinology 295
- Clinical Biochemistry 149
Countries citing papers authored by David C. Griffith
This map shows the geographic impact of David C. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Griffith more than expected).
Fields of papers citing papers by David C. Griffith
This network shows the impact of papers produced by David C. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Griffith. The network helps show where David C. Griffith may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Griffith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 383 | |
| 2 | 2017 | 305 | |
| 3 | 2018 | 271 | |
| 4 | 2020 | 191 | |
| 5 | 2006 | 189 | |
| 6 | 1997 | 185 | |
| 7 | 2022 | 123 | |
| 8 | 2015 | 103 | |
| 9 | 2018 | 72 | |
| 10 | 2016 | 71 | |
| 11 | 2011 | 64 | |
| 12 | 2009 | 52 | |
| 13 | 2018 | 51 | |
| 14 | 2009 | 47 | |
| 15 | 2018 | 44 | |
| 16 | 2021 | 44 | |
| 17 | 2017 | 41 | |
| 18 | 2020 | 41 | |
| 19 | 2010 | 41 | |
| 20 | 2008 | 40 |
About David C. Griffith
David C. Griffith is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology, having authored 67 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (39 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers), HIV/AIDS Research and Interventions (9 papers), Cystic Fibrosis Research Advances (9 papers), Pneumonia and Respiratory Infections (7 papers), Inhalation and Respiratory Drug Delivery (6 papers), Antibiotic Use and Resistance (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Applied Microbiology and Biotechnology (401 citations), Pharmacology (1.1k citations), Endocrinology (295 citations) and Clinical Biochemistry (149 citations). David C. Griffith has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Michael N. Dudley, Mojgan Sabet, Olga Lomovskaya, Ziad Tarazi, Debora Rubio-Aparicio, Mark A. Miller, Louise A. Kelly‐Hope, Dongxu Sun, Ruslan Tsivkovski and Kirk J. Nelson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, The Journal of Antibiotics, Journal of Adolescent Health and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.